4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-24-011568
Director bought 57,208 shares at $8.74 ($499,998)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamilton Thomas Edward Director | 2024-02-16 | Purchase | +57,208 | $8.74 | $499,998 | 564,798 | D: show line 1 in the form |
| Open-market purchases · 57,208 sh · avg $8.74 · $499,998 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hamilton Thomas Edward Director | 2024-05-29 | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…